journal article Open Access Oct 01, 2016

Pharmacogenomics of statins: understanding susceptibility to adverse effects

Joseph Kitzmiller Eduard Mikulik Anees Dauki Chandrama Mukherjee Jasmine Luzum

Pharmacogenomics and Personalized Medicine Vol. Volume 9 pp. 97-106 · Informa UK Limited

View at Publisher Save 10.2147/pgpm.s86013

Topics

No keywords indexed for this article. Browse by subject →

Metrics

46

Citations

0

References

Details

Published: Oct 01, 2016
Vol/Issue: Volume 9
Pages: 97-106
License: View

Authors

Joseph Kitzmiller

Chandrama Mukherjee

Cite This Article

Joseph Kitzmiller, Eduard Mikulik, Anees Dauki, et al. (2016). Pharmacogenomics of statins: understanding susceptibility to adverse effects. Pharmacogenomics and Personalized Medicine, Volume 9, 97-106. https://doi.org/10.2147/pgpm.s86013

Related

You May Also Like

Genetic Diversity Landscape in African Population: A Review of Implications for Personalized and Precision Medicine

Olivier Sibomana · 2024

14 citations

Long Non-Coding RNAs Gene Variants as Molecular Markers for Diabetic Retinopathy Risk and Response to Anti-VEGF Therapy

Hala MF Mohammad, Ahmed A Abdelghany · 2021

4 citations

The Efficacy of a Didactic and Case-Based Pharmacogenomics Education Program on Improving the Knowledge and Confidence of Alberta Pharmacists

Meagan Hayashi, Sherif Hanafy Mahmoud · 2022

3 citations

Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation

Yazun Jarrar, Sara Abudahab · 2023

2 citations

Non-Classical 21-Hydroxylase Deficiency: Analysis of a Mutant Gene in a Uyghur Family and Literature Review

Jimilanmu Maimaitiming, Guli Amuti · 2021

1 citations